Global Immuno-Oncology Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Immuno-Oncology market size was valued at US$ 67110 million in 2025 and is forecast to a readjusted size of US$ 171940 million by 2032 with a CAGR of 14.6% during review period.
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
The industry's leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.
This report is a detailed and comprehensive analysis for global Immuno-Oncology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Immuno-Oncology market size and forecasts, in consumption value ($ Million), 2021-2032
Global Immuno-Oncology market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Immuno-Oncology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Immuno-Oncology market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immuno-Oncology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immuno-Oncology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Immuno-Oncology market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immuno-Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-Oncology, with revenue, gross margin, and global market share of Immuno-Oncology from 2021 to 2026.
Chapter 3, the Immuno-Oncology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Immuno-Oncology market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-Oncology.
Chapter 13, to describe Immuno-Oncology research findings and conclusion.
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
The industry's leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.
This report is a detailed and comprehensive analysis for global Immuno-Oncology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Immuno-Oncology market size and forecasts, in consumption value ($ Million), 2021-2032
Global Immuno-Oncology market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Immuno-Oncology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Immuno-Oncology market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immuno-Oncology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immuno-Oncology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Immuno-Oncology market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Immune Checkpoint Inhibitors
- Cytokine-Based Immunotherapy
- Cancer Vaccines
- CAR-T Cell Therapy
- Others
- Hospitals
- Drugstores
- Others
- Bristol-Myers Squibb
- Merck & Co., Inc.
- Roche AG
- AstraZeneca, Plc
- Sanofi S.A.
- Dendreon Pharmaceuticals
- Novartis
- Gilead Sciences Inc.
- Merck KGaA
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immuno-Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-Oncology, with revenue, gross margin, and global market share of Immuno-Oncology from 2021 to 2026.
Chapter 3, the Immuno-Oncology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Immuno-Oncology market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-Oncology.
Chapter 13, to describe Immuno-Oncology research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immuno-Oncology by Type
1.3.1 Overview: Global Immuno-Oncology Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Immuno-Oncology Consumption Value Market Share by Type in 2025
1.3.3 Immune Checkpoint Inhibitors
1.3.4 Cytokine-Based Immunotherapy
1.3.5 Cancer Vaccines
1.3.6 CAR-T Cell Therapy
1.3.7 Others
1.4 Global Immuno-Oncology Market by Application
1.4.1 Overview: Global Immuno-Oncology Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospitals
1.4.3 Drugstores
1.4.4 Others
1.5 Global Immuno-Oncology Market Size & Forecast
1.6 Global Immuno-Oncology Market Size and Forecast by Region
1.6.1 Global Immuno-Oncology Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Immuno-Oncology Market Size by Region, (2021-2032)
1.6.3 North America Immuno-Oncology Market Size and Prospect (2021-2032)
1.6.4 Europe Immuno-Oncology Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Immuno-Oncology Market Size and Prospect (2021-2032)
1.6.6 South America Immuno-Oncology Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Immuno-Oncology Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Immuno-Oncology Product and Solutions
2.1.4 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.2 Merck & Co., Inc.
2.2.1 Merck & Co., Inc. Details
2.2.2 Merck & Co., Inc. Major Business
2.2.3 Merck & Co., Inc. Immuno-Oncology Product and Solutions
2.2.4 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Merck & Co., Inc. Recent Developments and Future Plans
2.3 Roche AG
2.3.1 Roche AG Details
2.3.2 Roche AG Major Business
2.3.3 Roche AG Immuno-Oncology Product and Solutions
2.3.4 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Roche AG Recent Developments and Future Plans
2.4 AstraZeneca, Plc
2.4.1 AstraZeneca, Plc Details
2.4.2 AstraZeneca, Plc Major Business
2.4.3 AstraZeneca, Plc Immuno-Oncology Product and Solutions
2.4.4 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 AstraZeneca, Plc Recent Developments and Future Plans
2.5 Sanofi S.A.
2.5.1 Sanofi S.A. Details
2.5.2 Sanofi S.A. Major Business
2.5.3 Sanofi S.A. Immuno-Oncology Product and Solutions
2.5.4 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sanofi S.A. Recent Developments and Future Plans
2.6 Dendreon Pharmaceuticals
2.6.1 Dendreon Pharmaceuticals Details
2.6.2 Dendreon Pharmaceuticals Major Business
2.6.3 Dendreon Pharmaceuticals Immuno-Oncology Product and Solutions
2.6.4 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Dendreon Pharmaceuticals Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Immuno-Oncology Product and Solutions
2.7.4 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Gilead Sciences Inc.
2.8.1 Gilead Sciences Inc. Details
2.8.2 Gilead Sciences Inc. Major Business
2.8.3 Gilead Sciences Inc. Immuno-Oncology Product and Solutions
2.8.4 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Gilead Sciences Inc. Recent Developments and Future Plans
2.9 Merck KGaA
2.9.1 Merck KGaA Details
2.9.2 Merck KGaA Major Business
2.9.3 Merck KGaA Immuno-Oncology Product and Solutions
2.9.4 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Merck KGaA Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Immuno-Oncology Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Immuno-Oncology by Company Revenue
3.2.2 Top 3 Immuno-Oncology Players Market Share in 2025
3.2.3 Top 6 Immuno-Oncology Players Market Share in 2025
3.3 Immuno-Oncology Market: Overall Company Footprint Analysis
3.3.1 Immuno-Oncology Market: Region Footprint
3.3.2 Immuno-Oncology Market: Company Product Type Footprint
3.3.3 Immuno-Oncology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Immuno-Oncology Consumption Value and Market Share by Type (2021-2026)
4.2 Global Immuno-Oncology Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Immuno-Oncology Consumption Value Market Share by Application (2021-2026)
5.2 Global Immuno-Oncology Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Immuno-Oncology Consumption Value by Type (2021-2032)
6.2 North America Immuno-Oncology Market Size by Application (2021-2032)
6.3 North America Immuno-Oncology Market Size by Country
6.3.1 North America Immuno-Oncology Consumption Value by Country (2021-2032)
6.3.2 United States Immuno-Oncology Market Size and Forecast (2021-2032)
6.3.3 Canada Immuno-Oncology Market Size and Forecast (2021-2032)
6.3.4 Mexico Immuno-Oncology Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Immuno-Oncology Consumption Value by Type (2021-2032)
7.2 Europe Immuno-Oncology Consumption Value by Application (2021-2032)
7.3 Europe Immuno-Oncology Market Size by Country
7.3.1 Europe Immuno-Oncology Consumption Value by Country (2021-2032)
7.3.2 Germany Immuno-Oncology Market Size and Forecast (2021-2032)
7.3.3 France Immuno-Oncology Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Immuno-Oncology Market Size and Forecast (2021-2032)
7.3.5 Russia Immuno-Oncology Market Size and Forecast (2021-2032)
7.3.6 Italy Immuno-Oncology Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Immuno-Oncology Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Immuno-Oncology Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Immuno-Oncology Market Size by Region
8.3.1 Asia-Pacific Immuno-Oncology Consumption Value by Region (2021-2032)
8.3.2 China Immuno-Oncology Market Size and Forecast (2021-2032)
8.3.3 Japan Immuno-Oncology Market Size and Forecast (2021-2032)
8.3.4 South Korea Immuno-Oncology Market Size and Forecast (2021-2032)
8.3.5 India Immuno-Oncology Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Immuno-Oncology Market Size and Forecast (2021-2032)
8.3.7 Australia Immuno-Oncology Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Immuno-Oncology Consumption Value by Type (2021-2032)
9.2 South America Immuno-Oncology Consumption Value by Application (2021-2032)
9.3 South America Immuno-Oncology Market Size by Country
9.3.1 South America Immuno-Oncology Consumption Value by Country (2021-2032)
9.3.2 Brazil Immuno-Oncology Market Size and Forecast (2021-2032)
9.3.3 Argentina Immuno-Oncology Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Immuno-Oncology Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Immuno-Oncology Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Immuno-Oncology Market Size by Country
10.3.1 Middle East & Africa Immuno-Oncology Consumption Value by Country (2021-2032)
10.3.2 Turkey Immuno-Oncology Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Immuno-Oncology Market Size and Forecast (2021-2032)
10.3.4 UAE Immuno-Oncology Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Immuno-Oncology Market Drivers
11.2 Immuno-Oncology Market Restraints
11.3 Immuno-Oncology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Immuno-Oncology Industry Chain
12.2 Immuno-Oncology Upstream Analysis
12.3 Immuno-Oncology Midstream Analysis
12.4 Immuno-Oncology Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immuno-Oncology by Type
1.3.1 Overview: Global Immuno-Oncology Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Immuno-Oncology Consumption Value Market Share by Type in 2025
1.3.3 Immune Checkpoint Inhibitors
1.3.4 Cytokine-Based Immunotherapy
1.3.5 Cancer Vaccines
1.3.6 CAR-T Cell Therapy
1.3.7 Others
1.4 Global Immuno-Oncology Market by Application
1.4.1 Overview: Global Immuno-Oncology Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospitals
1.4.3 Drugstores
1.4.4 Others
1.5 Global Immuno-Oncology Market Size & Forecast
1.6 Global Immuno-Oncology Market Size and Forecast by Region
1.6.1 Global Immuno-Oncology Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Immuno-Oncology Market Size by Region, (2021-2032)
1.6.3 North America Immuno-Oncology Market Size and Prospect (2021-2032)
1.6.4 Europe Immuno-Oncology Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Immuno-Oncology Market Size and Prospect (2021-2032)
1.6.6 South America Immuno-Oncology Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Immuno-Oncology Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Immuno-Oncology Product and Solutions
2.1.4 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.2 Merck & Co., Inc.
2.2.1 Merck & Co., Inc. Details
2.2.2 Merck & Co., Inc. Major Business
2.2.3 Merck & Co., Inc. Immuno-Oncology Product and Solutions
2.2.4 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Merck & Co., Inc. Recent Developments and Future Plans
2.3 Roche AG
2.3.1 Roche AG Details
2.3.2 Roche AG Major Business
2.3.3 Roche AG Immuno-Oncology Product and Solutions
2.3.4 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Roche AG Recent Developments and Future Plans
2.4 AstraZeneca, Plc
2.4.1 AstraZeneca, Plc Details
2.4.2 AstraZeneca, Plc Major Business
2.4.3 AstraZeneca, Plc Immuno-Oncology Product and Solutions
2.4.4 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 AstraZeneca, Plc Recent Developments and Future Plans
2.5 Sanofi S.A.
2.5.1 Sanofi S.A. Details
2.5.2 Sanofi S.A. Major Business
2.5.3 Sanofi S.A. Immuno-Oncology Product and Solutions
2.5.4 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sanofi S.A. Recent Developments and Future Plans
2.6 Dendreon Pharmaceuticals
2.6.1 Dendreon Pharmaceuticals Details
2.6.2 Dendreon Pharmaceuticals Major Business
2.6.3 Dendreon Pharmaceuticals Immuno-Oncology Product and Solutions
2.6.4 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Dendreon Pharmaceuticals Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Immuno-Oncology Product and Solutions
2.7.4 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Gilead Sciences Inc.
2.8.1 Gilead Sciences Inc. Details
2.8.2 Gilead Sciences Inc. Major Business
2.8.3 Gilead Sciences Inc. Immuno-Oncology Product and Solutions
2.8.4 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Gilead Sciences Inc. Recent Developments and Future Plans
2.9 Merck KGaA
2.9.1 Merck KGaA Details
2.9.2 Merck KGaA Major Business
2.9.3 Merck KGaA Immuno-Oncology Product and Solutions
2.9.4 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Merck KGaA Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Immuno-Oncology Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Immuno-Oncology by Company Revenue
3.2.2 Top 3 Immuno-Oncology Players Market Share in 2025
3.2.3 Top 6 Immuno-Oncology Players Market Share in 2025
3.3 Immuno-Oncology Market: Overall Company Footprint Analysis
3.3.1 Immuno-Oncology Market: Region Footprint
3.3.2 Immuno-Oncology Market: Company Product Type Footprint
3.3.3 Immuno-Oncology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Immuno-Oncology Consumption Value and Market Share by Type (2021-2026)
4.2 Global Immuno-Oncology Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Immuno-Oncology Consumption Value Market Share by Application (2021-2026)
5.2 Global Immuno-Oncology Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Immuno-Oncology Consumption Value by Type (2021-2032)
6.2 North America Immuno-Oncology Market Size by Application (2021-2032)
6.3 North America Immuno-Oncology Market Size by Country
6.3.1 North America Immuno-Oncology Consumption Value by Country (2021-2032)
6.3.2 United States Immuno-Oncology Market Size and Forecast (2021-2032)
6.3.3 Canada Immuno-Oncology Market Size and Forecast (2021-2032)
6.3.4 Mexico Immuno-Oncology Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Immuno-Oncology Consumption Value by Type (2021-2032)
7.2 Europe Immuno-Oncology Consumption Value by Application (2021-2032)
7.3 Europe Immuno-Oncology Market Size by Country
7.3.1 Europe Immuno-Oncology Consumption Value by Country (2021-2032)
7.3.2 Germany Immuno-Oncology Market Size and Forecast (2021-2032)
7.3.3 France Immuno-Oncology Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Immuno-Oncology Market Size and Forecast (2021-2032)
7.3.5 Russia Immuno-Oncology Market Size and Forecast (2021-2032)
7.3.6 Italy Immuno-Oncology Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Immuno-Oncology Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Immuno-Oncology Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Immuno-Oncology Market Size by Region
8.3.1 Asia-Pacific Immuno-Oncology Consumption Value by Region (2021-2032)
8.3.2 China Immuno-Oncology Market Size and Forecast (2021-2032)
8.3.3 Japan Immuno-Oncology Market Size and Forecast (2021-2032)
8.3.4 South Korea Immuno-Oncology Market Size and Forecast (2021-2032)
8.3.5 India Immuno-Oncology Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Immuno-Oncology Market Size and Forecast (2021-2032)
8.3.7 Australia Immuno-Oncology Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Immuno-Oncology Consumption Value by Type (2021-2032)
9.2 South America Immuno-Oncology Consumption Value by Application (2021-2032)
9.3 South America Immuno-Oncology Market Size by Country
9.3.1 South America Immuno-Oncology Consumption Value by Country (2021-2032)
9.3.2 Brazil Immuno-Oncology Market Size and Forecast (2021-2032)
9.3.3 Argentina Immuno-Oncology Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Immuno-Oncology Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Immuno-Oncology Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Immuno-Oncology Market Size by Country
10.3.1 Middle East & Africa Immuno-Oncology Consumption Value by Country (2021-2032)
10.3.2 Turkey Immuno-Oncology Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Immuno-Oncology Market Size and Forecast (2021-2032)
10.3.4 UAE Immuno-Oncology Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Immuno-Oncology Market Drivers
11.2 Immuno-Oncology Market Restraints
11.3 Immuno-Oncology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Immuno-Oncology Industry Chain
12.2 Immuno-Oncology Upstream Analysis
12.3 Immuno-Oncology Midstream Analysis
12.4 Immuno-Oncology Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF FIGURES
Table 1. Global Immuno-Oncology Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Immuno-Oncology Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Immuno-Oncology Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Immuno-Oncology Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 6. Bristol-Myers Squibb Major Business
Table 7. Bristol-Myers Squibb Immuno-Oncology Product and Solutions
Table 8. Bristol-Myers Squibb Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Bristol-Myers Squibb Recent Developments and Future Plans
Table 10. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 11. Merck & Co., Inc. Major Business
Table 12. Merck & Co., Inc. Immuno-Oncology Product and Solutions
Table 13. Merck & Co., Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Merck & Co., Inc. Recent Developments and Future Plans
Table 15. Roche AG Company Information, Head Office, and Major Competitors
Table 16. Roche AG Major Business
Table 17. Roche AG Immuno-Oncology Product and Solutions
Table 18. Roche AG Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. AstraZeneca, Plc Company Information, Head Office, and Major Competitors
Table 20. AstraZeneca, Plc Major Business
Table 21. AstraZeneca, Plc Immuno-Oncology Product and Solutions
Table 22. AstraZeneca, Plc Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. AstraZeneca, Plc Recent Developments and Future Plans
Table 24. Sanofi S.A. Company Information, Head Office, and Major Competitors
Table 25. Sanofi S.A. Major Business
Table 26. Sanofi S.A. Immuno-Oncology Product and Solutions
Table 27. Sanofi S.A. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Sanofi S.A. Recent Developments and Future Plans
Table 29. Dendreon Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 30. Dendreon Pharmaceuticals Major Business
Table 31. Dendreon Pharmaceuticals Immuno-Oncology Product and Solutions
Table 32. Dendreon Pharmaceuticals Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Dendreon Pharmaceuticals Recent Developments and Future Plans
Table 34. Novartis Company Information, Head Office, and Major Competitors
Table 35. Novartis Major Business
Table 36. Novartis Immuno-Oncology Product and Solutions
Table 37. Novartis Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Novartis Recent Developments and Future Plans
Table 39. Gilead Sciences Inc. Company Information, Head Office, and Major Competitors
Table 40. Gilead Sciences Inc. Major Business
Table 41. Gilead Sciences Inc. Immuno-Oncology Product and Solutions
Table 42. Gilead Sciences Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Gilead Sciences Inc. Recent Developments and Future Plans
Table 44. Merck KGaA Company Information, Head Office, and Major Competitors
Table 45. Merck KGaA Major Business
Table 46. Merck KGaA Immuno-Oncology Product and Solutions
Table 47. Merck KGaA Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Merck KGaA Recent Developments and Future Plans
Table 49. Global Immuno-Oncology Revenue (USD Million) by Players (2021-2026)
Table 50. Global Immuno-Oncology Revenue Share by Players (2021-2026)
Table 51. Breakdown of Immuno-Oncology by Company Type (Tier 1, Tier 2, and Tier 3)
Table 52. Market Position of Players in Immuno-Oncology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 53. Head Office of Key Immuno-Oncology Players
Table 54. Immuno-Oncology Market: Company Product Type Footprint
Table 55. Immuno-Oncology Market: Company Product Application Footprint
Table 56. Immuno-Oncology New Market Entrants and Barriers to Market Entry
Table 57. Immuno-Oncology Mergers, Acquisition, Agreements, and Collaborations
Table 58. Global Immuno-Oncology Consumption Value (USD Million) by Type (2021-2026)
Table 59. Global Immuno-Oncology Consumption Value Share by Type (2021-2026)
Table 60. Global Immuno-Oncology Consumption Value Forecast by Type (2027-2032)
Table 61. Global Immuno-Oncology Consumption Value by Application (2021-2026)
Table 62. Global Immuno-Oncology Consumption Value Forecast by Application (2027-2032)
Table 63. North America Immuno-Oncology Consumption Value by Type (2021-2026) & (USD Million)
Table 64. North America Immuno-Oncology Consumption Value by Type (2027-2032) & (USD Million)
Table 65. North America Immuno-Oncology Consumption Value by Application (2021-2026) & (USD Million)
Table 66. North America Immuno-Oncology Consumption Value by Application (2027-2032) & (USD Million)
Table 67. North America Immuno-Oncology Consumption Value by Country (2021-2026) & (USD Million)
Table 68. North America Immuno-Oncology Consumption Value by Country (2027-2032) & (USD Million)
Table 69. Europe Immuno-Oncology Consumption Value by Type (2021-2026) & (USD Million)
Table 70. Europe Immuno-Oncology Consumption Value by Type (2027-2032) & (USD Million)
Table 71. Europe Immuno-Oncology Consumption Value by Application (2021-2026) & (USD Million)
Table 72. Europe Immuno-Oncology Consumption Value by Application (2027-2032) & (USD Million)
Table 73. Europe Immuno-Oncology Consumption Value by Country (2021-2026) & (USD Million)
Table 74. Europe Immuno-Oncology Consumption Value by Country (2027-2032) & (USD Million)
Table 75. Asia-Pacific Immuno-Oncology Consumption Value by Type (2021-2026) & (USD Million)
Table 76. Asia-Pacific Immuno-Oncology Consumption Value by Type (2027-2032) & (USD Million)
Table 77. Asia-Pacific Immuno-Oncology Consumption Value by Application (2021-2026) & (USD Million)
Table 78. Asia-Pacific Immuno-Oncology Consumption Value by Application (2027-2032) & (USD Million)
Table 79. Asia-Pacific Immuno-Oncology Consumption Value by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Immuno-Oncology Consumption Value by Region (2027-2032) & (USD Million)
Table 81. South America Immuno-Oncology Consumption Value by Type (2021-2026) & (USD Million)
Table 82. South America Immuno-Oncology Consumption Value by Type (2027-2032) & (USD Million)
Table 83. South America Immuno-Oncology Consumption Value by Application (2021-2026) & (USD Million)
Table 84. South America Immuno-Oncology Consumption Value by Application (2027-2032) & (USD Million)
Table 85. South America Immuno-Oncology Consumption Value by Country (2021-2026) & (USD Million)
Table 86. South America Immuno-Oncology Consumption Value by Country (2027-2032) & (USD Million)
Table 87. Middle East & Africa Immuno-Oncology Consumption Value by Type (2021-2026) & (USD Million)
Table 88. Middle East & Africa Immuno-Oncology Consumption Value by Type (2027-2032) & (USD Million)
Table 89. Middle East & Africa Immuno-Oncology Consumption Value by Application (2021-2026) & (USD Million)
Table 90. Middle East & Africa Immuno-Oncology Consumption Value by Application (2027-2032) & (USD Million)
Table 91. Middle East & Africa Immuno-Oncology Consumption Value by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Immuno-Oncology Consumption Value by Country (2027-2032) & (USD Million)
Table 93. Global Key Players of Immuno-Oncology Upstream (Raw Materials)
Table 94. Global Immuno-Oncology Typical Customers
LIST OF FIGURES
Figure 1. Immuno-Oncology Picture
Figure 2. Global Immuno-Oncology Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Immuno-Oncology Consumption Value Market Share by Type in 2025
Figure 4. Immune Checkpoint Inhibitors
Figure 5. Cytokine-Based Immunotherapy
Figure 6. Cancer Vaccines
Figure 7. CAR-T Cell Therapy
Figure 8. Others
Figure 9. Global Immuno-Oncology Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Immuno-Oncology Consumption Value Market Share by Application in 2025
Figure 11. Hospitals Picture
Figure 12. Drugstores Picture
Figure 13. Others Picture
Figure 14. Global Immuno-Oncology Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 15. Global Immuno-Oncology Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 16. Global Market Immuno-Oncology Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 17. Global Immuno-Oncology Consumption Value Market Share by Region (2021-2032)
Figure 18. Global Immuno-Oncology Consumption Value Market Share by Region in 2025
Figure 19. North America Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 20. Europe Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 21. Asia-Pacific Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 22. South America Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 23. Middle East & Africa Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Immuno-Oncology Revenue Share by Players in 2025
Figure 26. Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 27. Market Share of Immuno-Oncology by Player Revenue in 2025
Figure 28. Top 3 Immuno-Oncology Players Market Share in 2025
Figure 29. Top 6 Immuno-Oncology Players Market Share in 2025
Figure 30. Global Immuno-Oncology Consumption Value Share by Type (2021-2026)
Figure 31. Global Immuno-Oncology Market Share Forecast by Type (2027-2032)
Figure 32. Global Immuno-Oncology Consumption Value Share by Application (2021-2026)
Figure 33. Global Immuno-Oncology Market Share Forecast by Application (2027-2032)
Figure 34. North America Immuno-Oncology Consumption Value Market Share by Type (2021-2032)
Figure 35. North America Immuno-Oncology Consumption Value Market Share by Application (2021-2032)
Figure 36. North America Immuno-Oncology Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Immuno-Oncology Consumption Value Market Share by Type (2021-2032)
Figure 41. Europe Immuno-Oncology Consumption Value Market Share by Application (2021-2032)
Figure 42. Europe Immuno-Oncology Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 44. France Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Immuno-Oncology Consumption Value Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Immuno-Oncology Consumption Value Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Immuno-Oncology Consumption Value Market Share by Region (2021-2032)
Figure 51. China Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 52. Japan Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 53. South Korea Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 54. India Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 55. Southeast Asia Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 56. Australia Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 57. South America Immuno-Oncology Consumption Value Market Share by Type (2021-2032)
Figure 58. South America Immuno-Oncology Consumption Value Market Share by Application (2021-2032)
Figure 59. South America Immuno-Oncology Consumption Value Market Share by Country (2021-2032)
Figure 60. Brazil Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 61. Argentina Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 62. Middle East & Africa Immuno-Oncology Consumption Value Market Share by Type (2021-2032)
Figure 63. Middle East & Africa Immuno-Oncology Consumption Value Market Share by Application (2021-2032)
Figure 64. Middle East & Africa Immuno-Oncology Consumption Value Market Share by Country (2021-2032)
Figure 65. Turkey Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 66. Saudi Arabia Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 67. UAE Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 68. Immuno-Oncology Market Drivers
Figure 69. Immuno-Oncology Market Restraints
Figure 70. Immuno-Oncology Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Immuno-Oncology Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Table 1. Global Immuno-Oncology Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Immuno-Oncology Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Immuno-Oncology Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Immuno-Oncology Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 6. Bristol-Myers Squibb Major Business
Table 7. Bristol-Myers Squibb Immuno-Oncology Product and Solutions
Table 8. Bristol-Myers Squibb Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Bristol-Myers Squibb Recent Developments and Future Plans
Table 10. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 11. Merck & Co., Inc. Major Business
Table 12. Merck & Co., Inc. Immuno-Oncology Product and Solutions
Table 13. Merck & Co., Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Merck & Co., Inc. Recent Developments and Future Plans
Table 15. Roche AG Company Information, Head Office, and Major Competitors
Table 16. Roche AG Major Business
Table 17. Roche AG Immuno-Oncology Product and Solutions
Table 18. Roche AG Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. AstraZeneca, Plc Company Information, Head Office, and Major Competitors
Table 20. AstraZeneca, Plc Major Business
Table 21. AstraZeneca, Plc Immuno-Oncology Product and Solutions
Table 22. AstraZeneca, Plc Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. AstraZeneca, Plc Recent Developments and Future Plans
Table 24. Sanofi S.A. Company Information, Head Office, and Major Competitors
Table 25. Sanofi S.A. Major Business
Table 26. Sanofi S.A. Immuno-Oncology Product and Solutions
Table 27. Sanofi S.A. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Sanofi S.A. Recent Developments and Future Plans
Table 29. Dendreon Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 30. Dendreon Pharmaceuticals Major Business
Table 31. Dendreon Pharmaceuticals Immuno-Oncology Product and Solutions
Table 32. Dendreon Pharmaceuticals Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Dendreon Pharmaceuticals Recent Developments and Future Plans
Table 34. Novartis Company Information, Head Office, and Major Competitors
Table 35. Novartis Major Business
Table 36. Novartis Immuno-Oncology Product and Solutions
Table 37. Novartis Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Novartis Recent Developments and Future Plans
Table 39. Gilead Sciences Inc. Company Information, Head Office, and Major Competitors
Table 40. Gilead Sciences Inc. Major Business
Table 41. Gilead Sciences Inc. Immuno-Oncology Product and Solutions
Table 42. Gilead Sciences Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Gilead Sciences Inc. Recent Developments and Future Plans
Table 44. Merck KGaA Company Information, Head Office, and Major Competitors
Table 45. Merck KGaA Major Business
Table 46. Merck KGaA Immuno-Oncology Product and Solutions
Table 47. Merck KGaA Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Merck KGaA Recent Developments and Future Plans
Table 49. Global Immuno-Oncology Revenue (USD Million) by Players (2021-2026)
Table 50. Global Immuno-Oncology Revenue Share by Players (2021-2026)
Table 51. Breakdown of Immuno-Oncology by Company Type (Tier 1, Tier 2, and Tier 3)
Table 52. Market Position of Players in Immuno-Oncology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 53. Head Office of Key Immuno-Oncology Players
Table 54. Immuno-Oncology Market: Company Product Type Footprint
Table 55. Immuno-Oncology Market: Company Product Application Footprint
Table 56. Immuno-Oncology New Market Entrants and Barriers to Market Entry
Table 57. Immuno-Oncology Mergers, Acquisition, Agreements, and Collaborations
Table 58. Global Immuno-Oncology Consumption Value (USD Million) by Type (2021-2026)
Table 59. Global Immuno-Oncology Consumption Value Share by Type (2021-2026)
Table 60. Global Immuno-Oncology Consumption Value Forecast by Type (2027-2032)
Table 61. Global Immuno-Oncology Consumption Value by Application (2021-2026)
Table 62. Global Immuno-Oncology Consumption Value Forecast by Application (2027-2032)
Table 63. North America Immuno-Oncology Consumption Value by Type (2021-2026) & (USD Million)
Table 64. North America Immuno-Oncology Consumption Value by Type (2027-2032) & (USD Million)
Table 65. North America Immuno-Oncology Consumption Value by Application (2021-2026) & (USD Million)
Table 66. North America Immuno-Oncology Consumption Value by Application (2027-2032) & (USD Million)
Table 67. North America Immuno-Oncology Consumption Value by Country (2021-2026) & (USD Million)
Table 68. North America Immuno-Oncology Consumption Value by Country (2027-2032) & (USD Million)
Table 69. Europe Immuno-Oncology Consumption Value by Type (2021-2026) & (USD Million)
Table 70. Europe Immuno-Oncology Consumption Value by Type (2027-2032) & (USD Million)
Table 71. Europe Immuno-Oncology Consumption Value by Application (2021-2026) & (USD Million)
Table 72. Europe Immuno-Oncology Consumption Value by Application (2027-2032) & (USD Million)
Table 73. Europe Immuno-Oncology Consumption Value by Country (2021-2026) & (USD Million)
Table 74. Europe Immuno-Oncology Consumption Value by Country (2027-2032) & (USD Million)
Table 75. Asia-Pacific Immuno-Oncology Consumption Value by Type (2021-2026) & (USD Million)
Table 76. Asia-Pacific Immuno-Oncology Consumption Value by Type (2027-2032) & (USD Million)
Table 77. Asia-Pacific Immuno-Oncology Consumption Value by Application (2021-2026) & (USD Million)
Table 78. Asia-Pacific Immuno-Oncology Consumption Value by Application (2027-2032) & (USD Million)
Table 79. Asia-Pacific Immuno-Oncology Consumption Value by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Immuno-Oncology Consumption Value by Region (2027-2032) & (USD Million)
Table 81. South America Immuno-Oncology Consumption Value by Type (2021-2026) & (USD Million)
Table 82. South America Immuno-Oncology Consumption Value by Type (2027-2032) & (USD Million)
Table 83. South America Immuno-Oncology Consumption Value by Application (2021-2026) & (USD Million)
Table 84. South America Immuno-Oncology Consumption Value by Application (2027-2032) & (USD Million)
Table 85. South America Immuno-Oncology Consumption Value by Country (2021-2026) & (USD Million)
Table 86. South America Immuno-Oncology Consumption Value by Country (2027-2032) & (USD Million)
Table 87. Middle East & Africa Immuno-Oncology Consumption Value by Type (2021-2026) & (USD Million)
Table 88. Middle East & Africa Immuno-Oncology Consumption Value by Type (2027-2032) & (USD Million)
Table 89. Middle East & Africa Immuno-Oncology Consumption Value by Application (2021-2026) & (USD Million)
Table 90. Middle East & Africa Immuno-Oncology Consumption Value by Application (2027-2032) & (USD Million)
Table 91. Middle East & Africa Immuno-Oncology Consumption Value by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Immuno-Oncology Consumption Value by Country (2027-2032) & (USD Million)
Table 93. Global Key Players of Immuno-Oncology Upstream (Raw Materials)
Table 94. Global Immuno-Oncology Typical Customers
LIST OF FIGURES
Figure 1. Immuno-Oncology Picture
Figure 2. Global Immuno-Oncology Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Immuno-Oncology Consumption Value Market Share by Type in 2025
Figure 4. Immune Checkpoint Inhibitors
Figure 5. Cytokine-Based Immunotherapy
Figure 6. Cancer Vaccines
Figure 7. CAR-T Cell Therapy
Figure 8. Others
Figure 9. Global Immuno-Oncology Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 10. Immuno-Oncology Consumption Value Market Share by Application in 2025
Figure 11. Hospitals Picture
Figure 12. Drugstores Picture
Figure 13. Others Picture
Figure 14. Global Immuno-Oncology Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 15. Global Immuno-Oncology Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 16. Global Market Immuno-Oncology Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 17. Global Immuno-Oncology Consumption Value Market Share by Region (2021-2032)
Figure 18. Global Immuno-Oncology Consumption Value Market Share by Region in 2025
Figure 19. North America Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 20. Europe Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 21. Asia-Pacific Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 22. South America Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 23. Middle East & Africa Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Immuno-Oncology Revenue Share by Players in 2025
Figure 26. Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 27. Market Share of Immuno-Oncology by Player Revenue in 2025
Figure 28. Top 3 Immuno-Oncology Players Market Share in 2025
Figure 29. Top 6 Immuno-Oncology Players Market Share in 2025
Figure 30. Global Immuno-Oncology Consumption Value Share by Type (2021-2026)
Figure 31. Global Immuno-Oncology Market Share Forecast by Type (2027-2032)
Figure 32. Global Immuno-Oncology Consumption Value Share by Application (2021-2026)
Figure 33. Global Immuno-Oncology Market Share Forecast by Application (2027-2032)
Figure 34. North America Immuno-Oncology Consumption Value Market Share by Type (2021-2032)
Figure 35. North America Immuno-Oncology Consumption Value Market Share by Application (2021-2032)
Figure 36. North America Immuno-Oncology Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Immuno-Oncology Consumption Value Market Share by Type (2021-2032)
Figure 41. Europe Immuno-Oncology Consumption Value Market Share by Application (2021-2032)
Figure 42. Europe Immuno-Oncology Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 44. France Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Immuno-Oncology Consumption Value Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Immuno-Oncology Consumption Value Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Immuno-Oncology Consumption Value Market Share by Region (2021-2032)
Figure 51. China Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 52. Japan Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 53. South Korea Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 54. India Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 55. Southeast Asia Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 56. Australia Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 57. South America Immuno-Oncology Consumption Value Market Share by Type (2021-2032)
Figure 58. South America Immuno-Oncology Consumption Value Market Share by Application (2021-2032)
Figure 59. South America Immuno-Oncology Consumption Value Market Share by Country (2021-2032)
Figure 60. Brazil Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 61. Argentina Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 62. Middle East & Africa Immuno-Oncology Consumption Value Market Share by Type (2021-2032)
Figure 63. Middle East & Africa Immuno-Oncology Consumption Value Market Share by Application (2021-2032)
Figure 64. Middle East & Africa Immuno-Oncology Consumption Value Market Share by Country (2021-2032)
Figure 65. Turkey Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 66. Saudi Arabia Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 67. UAE Immuno-Oncology Consumption Value (2021-2032) & (USD Million)
Figure 68. Immuno-Oncology Market Drivers
Figure 69. Immuno-Oncology Market Restraints
Figure 70. Immuno-Oncology Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Immuno-Oncology Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
